4.8 Article

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver

Tatiana Kisseleva

HEPATOLOGY (2017)

Review Pharmacology & Pharmacy

Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents

Katrin Bottcher et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Review Pharmacology & Pharmacy

Hepatic stellate cells as key target in liver fibrosis

Takaaki Higashi et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Article Biochemistry & Molecular Biology

Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway

Kuan-Hsing Chen et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Article Medicine, Research & Experimental

A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney

Frank Y. Ma et al.

LIFE SCIENCES (2016)

Article Gastroenterology & Hepatology

S100A4 promotes liver fibrosis via activation of hepatic stellate cells

Lin Chen et al.

JOURNAL OF HEPATOLOGY (2015)

Article Biochemical Research Methods

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

Ingmar Mederacke et al.

NATURE PROTOCOLS (2015)

Article Pharmacology & Pharmacy

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents

Dave Lengel et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)

Article Medicine, General & Internal

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

Ali A. Mokdad et al.

BMC MEDICINE (2014)

Article Chemistry, Medicinal

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Kevin S. Currie et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis

Weiwei Yang et al.

Article Gastroenterology & Hepatology

Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice

Juliane S. Troeger et al.

GASTROENTEROLOGY (2012)

Article Medicine, Research & Experimental

CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma

Jian Hong et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Medicine, General & Internal

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis.

Michael E. Weinblatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Immunology

The SYK tyrosine kinase: a crucial player in diverse biological functions

Attila Mocsai et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Review Pharmacology & Pharmacy

Transcriptional regulation of hepatic stellate cells

Jelena Mann et al.

ADVANCED DRUG DELIVERY REVIEWS (2009)

Article Oncology

Proteomic and Genetic Approaches Identify Syk as an AML Target

Cynthia K. Hahn et al.

CANCER CELL (2009)

Article Cell Biology

Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress

Henry E. Speich et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)

Article Biochemistry & Molecular Biology

Senescence of activated stellate cells limits liver fibrosis

Valery Krizhanovsky et al.

Review Medicine, General & Internal

Liver cirrhosis

Detlef Schuppan et al.

LANCET (2008)

Article Pharmacology & Pharmacy

A novel spleen tyrosine kinase inhibitor blocks c-jun N-terminal kinase-mediated gene expression in synoviocytes

HS Cha et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Review Gastroenterology & Hepatology

Transcriptional regulation of hepatic stellate cell activation

DA Mann et al.